Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...

According to a Moneycontrol poll of five brokerages, NTPC is likely to see an increase in revenue 9 percent to Rs 43,014 ...

The Delhi-based diversified conglomerate, DCM Shriram, saw its shares turn ex-dividend today, marking the last trading day ...